Intravenous tenecteplase

DRUG2 trials

Sponsors

NHS Greater Glasgow and Clyde, Hospital Moinhos de Vento

Conditions

Ischemic StrokeIschemic Stroke, Acute

Phase 3

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis

CompletedNCT02814409

NHS Greater Glasgow and ClydeIschemic Stroke

Start: 2016-12-15End: 2024-01-10Updated: 2024-06-13

Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT

RecruitingNCT05199662

Hospital Moinhos de VentoIschemic Stroke, Acute

Start: 2022-01-20End: 2027-07-31Target: 466Updated: 2025-04-04

Related Papers

Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial.

2024-11-0139 citations

Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study

Stroke and Vascular Neurology2021-08-2498 citations

Tenecteplase (and common sense) in short supply during the <scp>COVID</scp> ‐19 pandemic

The Medical Journal of Australia2020-10-244 citations